Comparative Pharmacology
Head-to-head clinical analysis: CYCLOCORT versus FLUOCET.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYCLOCORT versus FLUOCET.
CYCLOCORT vs FLUOCET
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production, inhibits phospholipase A2, and reduces prostaglandin synthesis.
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that potentiates serotonergic activity in the CNS by blocking the reuptake of serotonin into presynaptic neurons.
Apply a thin film topically to affected area twice daily (morning and evening). Not for ophthalmic use.
20 mg orally once daily in the morning.
None Documented
None Documented
3.5 hours (terminal); clinical effect duration longer due to tissue binding.
Fluoxetine: 4-6 days (single dose), 4-6 days (chronic); Norfluoxetine: 16 days. Clinical context: Steady state achieved after 4-5 weeks; extended half-life reduces withdrawal risk but prolongs washout.
Primarily hepatic metabolism; inactive metabolites excreted renally (<1% unchanged) and in feces (biliary).
Renal: 80% as fluoxetine and its metabolites (60% as glucuronide conjugates, 20% as parent and norfluoxetine). Fecal: 15% (biliary).
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid